While exact mechanisms can vary by compound, ALDN-084 is described in developer communications as acting on neurotransmitter systems and synaptic signaling involved in mood and emotional regulation. Investigational antidepressants often aim to:
The versatility of ALDN-084 is one of its most exciting aspects. This gene therapy has the potential to treat a broad spectrum of genetic disorders, including: ALDN-084